The 9th International Exhibition on Pharmaceuticals and Related Industries (Iran Pharma 2024) concluded successfully on October 4th at the Imam Khomeini Grand Mosalla mosque in central Tehran.

 

 Drawing over 750 domestic and international companies, the event was inaugurated by the Minister of Health, underscoring its importance in the pharmaceutical landscape.

As a key sponsor, the Razi Institute took center stage, showcasing its impressive capabilities in vaccine production. The institute's booth attracted significant interest from visitors, including health officials, industry representatives, and international experts. Notable discussions on potential collaborations in biological products were held with counterparts from India and China.

Ali Es-haghi, Director General of the Razi Institute, emphasized the institute's comprehensive vaccine portfolio, encompassing polio, measles, rubella, mumps, tetanus, and diphtheria, as well as therapeutic serums for snake and scorpion bites. He highlighted the institute's commitment to not only meeting domestic needs but also contributing to regional public health by exporting vaccines to neighboring countries.

The exhibition provided a valuable platform for Razi Institute to strengthen its connections within the pharmaceutical sector and showcase its vital role in public health. Beyond networking, the event aimed to boost export potential, particularly to neighboring countries. Razi Institute's active participation reaffirmed its position as a leading producer of biological products in Iran, driving the nation's vaccination initiatives and overall health strategy.